Target intelligence / Profile preview

RNA, U6 small nuclear 1220, pseudogene (RNU6-1220P)

Target
RNU6-1220P
Molecular classification
Pseudogene, Noncoding RNA, Small nuclear RNA pseudogene, Other
01

Overview

RNA, U6 small nuclear 1220, pseudogene (RNU6-1220P) is classified as a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential component of the spliceosome, the complex responsible for pre-mRNA splicing in eukaryotic cells[3][5][1]. However, RNU6-1220P is a pseudogene—it is a nonfunctional, typically non-expressed sequence that has lost its original gene function due to mutations and retrotranspositional events[7][8]. Pseudogenes of U6 snRNA, such as RNU6-1220P, do not produce a functional RNA or protein product and are not involved in canonical biological processes or disease roles. They are generally considered genomic fossils and are not recognized as therapeutic targets or biomarkers[8]. There is no evidence to suggest that RNU6-1220P has a functional role in human biology, nor is it known to interact with any drugs, participate in pathogenic mechanisms, or raise specific safety concerns. Note: - This entry refers to a pseudogene, not a functional gene, protein, or therapeutic target, and is not relevant in the context of drug discovery or therapeutic intervention[8][7]. - If you are interested in the functional U6 snRNA, refer to U6 small nuclear RNA, which is central to pre-mRNA splicing[3][1].

Other names
RNU6-1220PRNA, U6 Small Nuclear 1220, PseudogeneU6 snRNA pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 1220, pseudogene (RNU6-1220P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1220, pseudogene (RNU6-1220P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call